Senior insider sale
Chief Financial Officer at NURIX THERAPEUTICS, INC. — senior position signals high conviction
$238.0K
14.05K shares
What this filing means
VAN HOUTE HANS plans to sell 14.05K shares of NURIX THERAPEUTICS, INC. valued at approximately $238.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/5/2026ACC: 0001950047-26-004048
Officer· Chief Financial Officer
Since Jul 2020
14.05K
Shares to sell
$238.0K
Approx. market value
14.05K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/30/2026
14.05KTotal acquired14.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/30/2026 | Restricted Stock Units N/A | 14.05K | — |
| Total | 14.05K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
14.05K
Market value
$238.0K
5/5/2026
Total
Units
14.05K
Value
$238.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/5/2026 | 14.05K | $238.0K | NASDAQ | Planned |
| Total | 14.05K | $238.0K | ||